Skip to main content

Table 1 Demographic and clinical characteristics, postoperative treatment, and outcome at baseline of participants in this study

From: Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer

Characteristics Number (%) Characteristics Number (%)
Gender   Surgical margin  
 Male 94 (55.6)  Negative 163 (96.4)
 Female 75 (44.4)  Positive 6 (3.6)
Age (yr, average, range) 70.5 (29–92) Glucose tolerance  
Preoperative serum CEA value    Normal 120 (71.0)
  < 5 106 (62.7)  Abnormal 49 (29.0)
  ≥ 5 63 (37.3) Obstruction / perforation  
Preoperative serum CA19–9 value    Absence 157 (92.9)
  < 37 143 (84.6)  Presence 12 (7.1)
  ≥ 37 26 (15.4) Surgical approach  
Tumor location    Laparotomy 101 (59.8)
 Right 88 (52.1)  Laparoscopic surgery 68 (40.2)
 Left 81 (47.9) Examined lymph node  
Tumor size (cm, average, range) 5.0 (1–17)   ≥ 12 115 (68.0)
Differentiation     < 12 54 (32.0)
 Well, Mod, pap 150 (88.8) Postoperative adjuvant chemotherapy  
 Por, Muc, Sig 19 (11.2)  No 147 (86.1)
pT category    Yes 22 (13.9)
 pT3 144 (85.2) Postoperative relapse n = 23
 pT4a 13 (7.7)  Lung 6
 pT4b 12 (7.1)  Liver 8
Lymphatic invasion    Peritoneum 5
 Absent 104 (61.5)  Paraaortic lymph node 3
 Present 65 (38.5)  Local relapse 1
Vessel invasion   Desmoplastic reaction  
 Absent 71 (42.0)  Mature stroma 76 (45.0)
 Present 98 (58.0)  Intermediate stroma 62 (36.1)
Tumor budding    Myxoid (i.e. immature) stroma 32 (18.9)
 Grade 1 106 (62.7)   
 Grade 2 43 (25.4)   
 Grade 3 20 (11.9)